期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 18, 期 4, 页码 777-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2004.07.003
关键词
-
This article challenges the assertion that current levels of antibacterial drug resistance should influence treatment decisions for patients who have community-acquired pneumonia (CAP). The article will discuss the following topics related to patients who have CAP: (1) the relevant bacteriologic and clinical outcomes that should be investigated to inform empirical treatment, (2) the study design options for studying the impact of antibacterial drug resistance on bacteriologic and clinical outcomes, and (3) the evidence that antibacterial drug resistance influences bacteriologic and clinical outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据